Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice

No abstract is available for this paper.

• Publication year

  2009

• Venue

  British Journal of Pharmacology

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1111/j.1476-5381.2009.00295.xPMID 19552690PMCID PMC2743846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's disease.

  2011cited by this paper
• Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.

  2008cited by this paper
• Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study.

  2008influential reference
• Panaxydol and panaxynol protect cultured cortical neurons against Abeta25-35-induced toxicity.

  2008cited by this paper
• Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35).

  2008cited by this paper
• Protective Effects of Piceatannol against Beta‐Amyloid–Induced Neuronal Cell Death

  2007cited by this paper
• A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25-35).

  2007cited by this paper
• The molecular mechanisms of the anti-amyloid effects of phenols

  2007cited by this paper
• A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ25–35

  2007cited by this paper
• Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism

  2006cited by this paper
• The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor

  2006cited by this paper
• The use of classification methods for modeling the antioxidant activity of flavonoid compounds

  2006cited by this paper
• Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42.

  2006cited by this paper
• Alzheimer's disease

  2006cited by this paper
• Single Chain Fv Antibodies against the 25−35 Aβ Fragment Inhibit Aggregation and Toxicity of Aβ42†

  2006cited by this paper
• Silybin and silymarin--new effects and applications.

  2005cited by this paper
• Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

  2003cited by this paper
• Anti-apoptotic proteins are oxidized by Abeta25-35 in Alzheimer's fibroblasts.

  2003cited by this paper
• Administration of Aggregated Beta-Amyloid Peptide (25–35) Induces Changes in Long-Term Potentiation in the Hippocampus in Vivo

  2003cited by this paper
• In vivo conversion of racemized β‐amyloid ([D‐Ser26]Aβ1–40) to truncated and toxic fragments ([D‐Ser26]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients

  2002cited by this paper
• The protective effects of melatonin from oxidative damage induced by amyloid beta‐peptide 25–35 in middle‐aged rats

  2002cited by this paper
• Silymarin protects dopaminergic neurons against lipopolysaccharide‐induced neurotoxicity by inhibiting microglia activation

  2002cited by this paper
• Pharmacotherapy for Alzheimer's disease: progress and prospects.

  2002cited by this paper
• In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.

  2002influential reference
• Milk thistle for the treatment of liver disease: a systematic review and meta-analysis.

  2002cited by this paper
• Redox-active iron mediates amyloid-beta toxicity.

  2001cited by this paper
• Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

  2001cited by this paper
• Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease.

  2001cited by this paper
• Flavonoids: a review of probable mechanisms of action and potential applications.

  2001cited by this paper
• Redox-active iron mediates amyloid-β toxicity

  2001cited by this paper
• Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit.

  2001cited by this paper
• Silybin, a new iron-chelating agent.

  2001cited by this paper
• Participation of manganese-superoxide dismutase in the neuroprotection exerted by copper sulfate against 1-methyl 4-phenylpyridinium neurotoxicity.

  2001cited by this paper
• Amyloid β‐peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors

  2001cited by this paper
• Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level.

  2001cited by this paper
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

  2000cited by this paper
• Protective effects of the flavonoid mixture, silymarin, on fetal rat brain and liver.

  1999cited by this paper
• Presenilins, the Endoplasmic Reticulum, and Neuronal Apoptosis in Alzheimer's Disease

  1998cited by this paper
• Tissue injury by reactive oxygen species and the protective effects of flavonoids

  1998cited by this paper
• Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

  1998cited by this paper
• Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*)

  1996influential reference
• Mechanisms of neuronal degeneration in Alzheimer's disease.

  1996cited by this paper
• Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

  1996influential reference
• Oxidative damage in Alzheimer's

  1996cited by this paper
• Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

  1996cited by this paper
• Amyloid peptides are toxic via a common oxidative mechanism.

  1995cited by this paper
• Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

  1995cited by this paper
• Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.

  1995cited by this paper
• Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes.

  1992cited by this paper
• Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme.

  1991cited by this paper
• Selectivity of Silymarin on the Increase of the Glutathione Content in Different Tissues of the Rat

  1989cited by this paper
• Overview of methods used for detecting lipid peroxidation.

  1984cited by this paper
• The FASEB Journal • Research Communication Oral

  year unknowncited by this paper
• Hyperfunction of Dopaminergic and Serotonergic Neuronal Systems in Mice Lacking the Nmda Receptor ⑀1 Subunit

  year unknowncited by this paper

• Dietary Isoflavone Biochanin A Attenuates Aluminium Chloride-Induced Sporadic Alzheimer’s Disease and Associated Neurobehavioral Alterations Through NRF2-HO1 Pathway Activation and NLRP3 Inflammasome Suppression

  2026cites this paper
• Silibinin-loaded PEGylated niosomal nanoparticles restore hippocampus histological changes, memory and learning, and downregulate the inflammasome pathway in Alzheimer's disease animal models.

  2026cites this paper
• Exploring Alzheimer's Disease Treatment: Established Therapies and Novel Strategies for Future Care.

  2025cites this paper
• Phytomolecules as Alzheimer's therapeutics: A comprehensive review.

  2025cites this paper
• Silibinin-derived microbiota enrich (R)-2,3-dihydroxy-isovalerate and ameliorate colitis via the GAT-3/RARβ/RORγt axis

  2025cites this paper
• Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer’s Disease and Other Neurological Disorders

  2025cites this paper
• Neuroprotective effect of silibinin linked with attenuated Interleukin-6 and TNFα in an Aβ1-40 Induced Alzheimer’s rat model

  2025cites this paper
• Bibliometric and Visual Analysis of Herbal Medicine on Cognitive Impairment over the Past 20 Years

  2025cites this paper
• Deciphering Alzheimer's disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier.

  2025cites this paper
• Multi-omics analysis reveals the molecular mechanism of silibinin rescue the toxic effects of butyl benzyl phthalate on porcine preimplantation embryos.

  2025cites this paper
• Multi‐Targeting Phytochemicals for Alzheimer's Disease

  2025cites this paper
• Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications

  2025cites this paper
• Ameliorative Effects of Silymarin on Methamphetamine-Induced Neurobehavioral and Histopathological Alterations in Adolescent Wistar Rats

  2025influential citation
• Protective effects of Silibinin and cinnamic acid against paraquat-induced lung toxicity in rats: impact on oxidative stress, PI3K/AKT pathway, and miR-193a signaling

  2024influential citation
• A review of the botany, phytochemistry, pharmacology, synthetic biology and comprehensive utilization of Silybum marianum

  2024cites this paper
• In-situ polyherbal gel as biomedicine in the management of Alzheimer's disease: Understanding ameliorative potential in Trimethyltin induced neurodegeneration.

  2024cites this paper
• Targeting Amyloids with Coated Nanoparticles: A Review on Potential Combinations of Nanoparticles and Bio-Compatible Coatings.

  2024cites this paper
• Development of silibinin-loaded nanostructured lipid carriers for Alzheimer's disease induced by amyloid beta in Wistar rats.

  2024cites this paper
• Formulation and Characterization of Silibinin Entrapped Nano-Liquid Crystals for Activity against Aβ1-42 Neurotoxicity in In-Vivo Model

  2024cites this paper
• Histological and Biochemical Evaluation of Silibinin in Treatment of Periodontitis Induced in Rats with Liver Cirrhosis.

  2024cites this paper
• Staphylococcus aureus major cell division protein FtsZ assembly is inhibited by silibinin, a natural flavonolignan that also blocked bacterial growth and biofilm formation.

  2024cites this paper
• Silymarin Nanoparticles Counteract Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights into Mitochondrial Dysfunction and Nrf2/HO-1 Axis.

  2024cites this paper
• Intranasal administration of silibinin-loaded pullulan acetate nanocarriers: A pH-responsive approach for brain targeting in Alzheimer's disease

  2024cites this paper
• Review on anti-alzheimer drug development: approaches, challenges and perspectives

  2024cites this paper
• Platycodin D stimulates AMPK activity to inhibit the neurodegeneration caused by reactive oxygen species-induced inflammation and apoptosis.

  2023cites this paper
• Polycaprolactan/ tragacanth nanoscaffold enriched with sililymarin as a protector of neural progenitor cells under oxidative stress conditions

  2023cites this paper
• Silibinin effects on cognitive disorders: Hope or treatment?

  2023cites this paper
• Brazilian green propolis prevent Alzheimer’s disease-like cognitive impairment induced by amyloid beta in mice

  2023cites this paper
• Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer’s Disease

  2023cites this paper
• Silibinin Attenuates Experimental Periodontitis by Downregulation of Inflammation and Oxidative Stress

  2023cites this paper
• Nootropic effect of Indian Royal Jelly against okadaic acid induced rat model of Alzheimer's disease: Inhibition of neuroinflammation and acetylcholineesterase

  2023cites this paper
• Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight

  2023cites this paper
• Potential implications of polyphenolic compounds in neurodegenerative diseases

  2022cites this paper
• Standardization and Ameliorative effect of Kalyanaka ghrita in β-amyloid induced memory impairment in wistar rats.

  2022cites this paper
• Silibinin Improves the Clinical Scores of Memory Function in Patients with Mild Cognitive Impairment: A Double-Blind, Placebo-Controlled Pilot Study

  2022cites this paper
• Mechanistic Insights into the Pharmacological Significance of Silymarin

  2022cites this paper
• Box Behnken Design Optimized Silibinin Loaded Glycerylmonooleate Nanoliquid Crystal for Brain Targeting.

  2022cites this paper
• ERp57 chaperon protein protects neuronal cells from Aβ‐induced toxicity

  2022cites this paper
• Silibinin Ameliorates Formaldehyde-Induced Cognitive Impairment by Inhibiting Oxidative Stress

  2022cites this paper
• Investigation of an Increase in the Expression of the Mir146a Gene in The Hippocampus and a Decrease in the Levels of Blood Sugar, Insulin, and Insulin Resistance in Elderly Diabetic Rats after a Period of High-Intensity Interval Training

  2022cites this paper
• Toxicity Profiles of Kleeb Bua Daeng Formula, a Traditional Thai Medicine, and Its Protective Effects on Memory Impairment in Animals

  2022influential citation
• The Aqueous Extract of Humulus japonicus Ameliorates Cognitive Dysfunction in Alzheimer's Disease Models via Modulating the Cholinergic System

  2022cites this paper
• Protective role of silibinin over nickel sulfate-induced reproductive toxicity in male rats.

  2021influential citation
• Anredera cordifolia extract enhances learning and memory in senescence-accelerated mouse-prone 8 (SAMP8) mice.

  2021cites this paper
• Advancement in cytoprotection through suppression of p53 protein

  2021cites this paper
• Reduced Cerebral Glucose Uptake in an Alzheimer’s Rat Model With Glucose-Weighted Chemical Exchange Saturation Transfer Imaging

  2021cites this paper
• Silibinin Attenuates Motor Dysfunction in a Mouse Model of Parkinson's Disease by Suppression of Oxidative Stress and Neuroinflammation along with Promotion of Mitophagy.

  2021cites this paper
• The Role of Natural Antioxidants in the Prevention of Dementia—Where Do We Stand and Future Perspectives

  2021cites this paper
• Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: A comprehensive review.

  2021cites this paper
• EXPERMENTAL MODELS FOR MEMORY IMPAIRMENT

  2021cites this paper
• Investigation on the solid-phase synthesis of silybin prodrugs and their timed-release.

  2021cites this paper
• Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin

  2021cites this paper
• Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer’s Disease

  2021cites this paper
• Protective Effects of Silibinin on Helicobacter pylori-induced Gastritis: NF-κB and STAT3 as Potential Targets

  2021cites this paper
• Probing the intermolecular interactions, binding affinity, charge density distribution and dynamics of silibinin in dual targets AChE and BACE1: QTAIM and molecular dynamics perspective

  2021cites this paper
• Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice

  2020cites this paper
• No Synergistic Effect of Silibinin and Morin in a Kainic Acid-Induced Epileptic Mouse Model

  2020cites this paper
• Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity.

  2020cites this paper
• Silibinin prevents depression-like behaviors in a single prolonged stress rat model: the possible role of serotonin

  2020cites this paper
• Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications.

  2020cites this paper
• Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms.

  2020cites this paper
• The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and Clinical Evidence.

  2020cites this paper
• Treating Alzheimer’s disease pathology: Present to alternative modalities

  2020cites this paper
• Phytol loaded PLGA nanoparticles ameliorate scopolamine-induced cognitive dysfunction by attenuating cholinesterase activity, oxidative stress and apoptosis in Wistar rat

  2020cites this paper
• Significant combination of Aβ aggregation inhibitory and neuroprotective properties in silico, in vitro and in vivo by bis(propyl)-cognitin, a multifunctional anti-Alzheimer's agent.

  2020cites this paper
• Evaluation of the effect of thymoquinone in d‐galactose‐induced memory impairments in rats: Role of MAPK, oxidative stress, and neuroinflammation pathways and telomere length

  2020cites this paper
• Sterubin: Enantioresolution and Configurational Stability, Enantiomeric Purity in Nature, and Neuroprotective Activity in Vitro and in Vivo

  2020cites this paper
• Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease

  2019cites this paper
• 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo

  2019cites this paper
• Effects of Silibinin Against Prothrombin Kringle-2-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System In Vivo

  2019cites this paper
• Silymarin and silymarin nanoparticles guard against chronic unpredictable mild stress induced depressive-like behavior in mice: involvement of neurogenesis and NLRP3 inflammasome

  2019cites this paper
• Silibinin ameliorates diabetic nephropathy via improving diabetic condition in the mice

  2019cites this paper
• Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation.

  2019cites this paper
• Regulation of gut microbiota in Alzheimer’s disease mice by silibinin and silymarin and their pharmacological implications

  2019cites this paper
• Protective Effect of Hot Water Extract of Loliolus Beka Gray Meat Against Palmitate-Induced HUVEC Damage.

  2019cites this paper
• Silibinin induced apoptosis of human epidermal cancer A431 cells by promoting mitochondrial NOS

  2019cites this paper
• Oxidative stress and related gene expression effects of cyfluthrin in human neuroblastoma SH-SY5Y cells: Protective effect of melatonin.

  2019cites this paper
• Moderate- and Low-Dose of Atorvastatin Alleviate Cognition Impairment Induced by High-Fat Diet via Sirt1 Activation

  2019cites this paper
• Involvement of GAT2/BGT‐1 in the preventive effects of betaine on cognitive impairment and brain oxidative stress in amyloid &bgr; peptide‐injected mice

  2019cites this paper
• Ameliorative Effects of Different Transcranial Electrical Stimulation Paradigms on the Novel Object Recognition Task in a Rat Model of Alzheimer Disease

  2019cites this paper
• Natural silibinin modulates amyloid precursor protein processing and amyloid-β protein clearance in APP/PS1 mice

  2019cites this paper
• Silibinin Alleviates the Learning and Memory Defects in Overtrained Rats Accompanying Reduced Neuronal Apoptosis and Senescence

  2019cites this paper
• The cytogenetic effects of silibinin alone and in combination with methotrexate in mouse bone marrow

  2018cites this paper
• Evaluation of chemical composition, antioxidant and anti-acetylcholinesterase activities of Hypericum neurocalycinum and Hypericum malatyanum

  2018cites this paper
• A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases

  2018cites this paper
• Long‑term behavioral, histological, biochemical and hematological evaluations of amyloid beta‑induced Alzheimer's disease in rat.

  2018cites this paper
• Investigations into neuroprotectivity, stability, and water solubility of 7‐O‐cinnamoylsilibinin, its hemisuccinate and dehydro derivatives

  2018cites this paper
• Protective effects of silibinin on insulin amyloid fibrillation, cytotoxicity and mitochondrial membrane damage.

  2018cites this paper
• STUDY THE EFFECT OF SILIBININ ON EXPERIMENTALLY INDUCED MEMORY IMPAIRMENT IN MALE RATS.

  2018cites this paper
• Milk thistle (Silybum Marianum) as an antidote or a protective agent against natural or chemical toxicities: a review

  2018cites this paper
• Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.

  2018cites this paper
• Silibinin exerts antidepressant effects by improving neurogenesis through BDNF/TrkB pathway

  2018cites this paper
• Recent Trends in Drug Discovery against Alzheimer's Disease: Use of Natural Products and Nutraceuticals from Botanicals

  2018cites this paper
• The modulatory role of phloretin in Aβ25–35 induced sporadic Alzheimer’s disease in rat model

  2018cites this paper
• Therapeutic benefits of Ursolic acid in Parkinson’s, Alzheimer’s and Psychiatric diseases

  2018cites this paper
• Estrogen Receptors Are Involved in the Neuroprotective Effect of Silibinin in Aβ1–42-Treated Rats

  2018cites this paper
• Dietary and antioxidant therapy for autistic children: Does it really work?

  2018cites this paper
• Phytochemical constituents from dietary plant Citrus hystrix

  2018cites this paper
• Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry.

  2017cites this paper
• Silibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus.

  2017cites this paper